JP2024520861A5 - - Google Patents
Info
- Publication number
- JP2024520861A5 JP2024520861A5 JP2023577141A JP2023577141A JP2024520861A5 JP 2024520861 A5 JP2024520861 A5 JP 2024520861A5 JP 2023577141 A JP2023577141 A JP 2023577141A JP 2023577141 A JP2023577141 A JP 2023577141A JP 2024520861 A5 JP2024520861 A5 JP 2024520861A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- compound
- isovaleric acid
- palm
- lys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163210453P | 2021-06-14 | 2021-06-14 | |
| US63/210,453 | 2021-06-14 | ||
| US202163252001P | 2021-10-04 | 2021-10-04 | |
| US63/252,001 | 2021-10-04 | ||
| US202263349841P | 2022-06-07 | 2022-06-07 | |
| US63/349,841 | 2022-06-07 | ||
| PCT/US2022/033378 WO2022266060A1 (en) | 2021-06-14 | 2022-06-14 | Hepcidin mimetics for treatment of hereditary hemochromatosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520861A JP2024520861A (ja) | 2024-05-24 |
| JP2024520861A5 true JP2024520861A5 (https=) | 2025-06-23 |
Family
ID=84527344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577141A Pending JP2024520861A (ja) | 2021-06-14 | 2022-06-14 | 遺伝性ヘモクロマトーシスの治療のためのヘプシジン模倣体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240293511A1 (https=) |
| EP (2) | EP4355763A4 (https=) |
| JP (1) | JP2024520861A (https=) |
| KR (1) | KR20240021833A (https=) |
| AU (1) | AU2022293672A1 (https=) |
| BR (1) | BR112023026381A2 (https=) |
| CA (1) | CA3220871A1 (https=) |
| IL (1) | IL309166A (https=) |
| MX (1) | MX2023015021A (https=) |
| TW (1) | TW202317604A (https=) |
| WO (1) | WO2022266060A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4091624A1 (en) | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| HRP20211448T1 (hr) | 2014-05-16 | 2021-12-24 | Protagonist Therapeutics, Inc. | Alfa4beta7 integrin tioeter peptidni antagonisti |
| CN107206254B (zh) | 2014-07-17 | 2021-08-24 | 领导医疗有限公司 | 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途 |
| CA3089868A1 (en) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| AU2021209086A1 (en) | 2020-01-15 | 2022-08-04 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| CA3167751A1 (en) | 2020-01-15 | 2021-07-22 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| JP7397239B2 (ja) | 2020-11-20 | 2023-12-12 | ヤンセン ファーマシューティカ エヌ．ベー． | インターロイキン－２３受容体のペプチド阻害剤の組成物 |
| EP4370146A4 (en) | 2021-07-14 | 2025-05-21 | Janssen Biotech, Inc. | Lipidated peptide inhibitors of the interleukin-23 receptor |
| WO2025207760A1 (en) * | 2024-03-27 | 2025-10-02 | Protagonist Therapeutics, Inc. | Formulations of a hepcidin peptide analogue |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4091624A1 (en) * | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| WO2015200916A2 (en) * | 2014-06-27 | 2015-12-30 | Protagonist Therapeutics, Inc. | Hepcidin and mini-hepcidin analogues and uses therof |
| EP3240799B1 (en) * | 2014-12-29 | 2021-03-31 | The Regents of the University of California | S-alkylated hepcidin peptides and methods of making and using thereof |
| US20190002503A1 (en) * | 2015-12-30 | 2019-01-03 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| PH12022550510A1 (en) * | 2019-09-03 | 2023-09-04 | Protagonist Therapeutics Inc | Conjugated hepcidin mimetics |
-
2022
- 2022-06-14 IL IL309166A patent/IL309166A/en unknown
- 2022-06-14 EP EP22825644.2A patent/EP4355763A4/en active Pending
- 2022-06-14 JP JP2023577141A patent/JP2024520861A/ja active Pending
- 2022-06-14 KR KR1020237044819A patent/KR20240021833A/ko active Pending
- 2022-06-14 CA CA3220871A patent/CA3220871A1/en active Pending
- 2022-06-14 AU AU2022293672A patent/AU2022293672A1/en active Pending
- 2022-06-14 BR BR112023026381A patent/BR112023026381A2/pt unknown
- 2022-06-14 TW TW111122040A patent/TW202317604A/zh unknown
- 2022-06-14 US US18/570,004 patent/US20240293511A1/en active Pending
- 2022-06-14 WO PCT/US2022/033378 patent/WO2022266060A1/en not_active Ceased
- 2022-06-14 EP EP26151778.3A patent/EP4737477A2/en active Pending
- 2022-06-14 MX MX2023015021A patent/MX2023015021A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024520861A5 (https=) | ||
| JP2022546878A5 (https=) | ||
| US12269856B2 (en) | Hepcidin analogues and uses thereof | |
| JP2024520861A (ja) | 遺伝性ヘモクロマトーシスの治療のためのヘプシジン模倣体 | |
| JP2025163134A (ja) | コンジュゲートされたヘプシジン模倣物 | |
| JP2003522721A5 (https=) | ||
| JP2005120094A5 (https=) | ||
| JP2024513391A5 (https=) | ||
| US7452865B2 (en) | Antagonistic analogs of GH RH (2003) | |
| CN101983068B (zh) | N末端和c末端取代的人gh-rh拮抗类似物 | |
| TW585873B (en) | Antagonistic analogs of GH-RH inhibiting IGF-I and -II | |
| CA2337667C (en) | Dextran-leptin conjugates, pharmaceutical compositions and related methods | |
| EP3094643B1 (en) | Lipidated peptides for lowering blood glucose | |
| WO2024011188A1 (en) | Combination therapy for treatment of iron overload diseases | |
| KR100240434B1 (ko) | 구조적으로 변형된 혈관작용성 소장 펩티드(vip)의 유도체 및 이를 함유한 제약 조성물 | |
| TW476650B (en) | Use of a cytokine regulatory agent to treat rheumatoid arthritis | |
| HK1220112B (en) | Hepcidin analogues and uses therof |